Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Achieve Life Sciences - 29 Year Stock Price History | ACHV

Historical daily share price chart and data for Achieve Life Sciences since 1995 adjusted for splits and dividends. The latest closing stock price for Achieve Life Sciences as of April 30, 2024 is 4.39.
  • The all-time high Achieve Life Sciences stock closing price was 1821599.82 on October 08, 1997.
  • The Achieve Life Sciences 52-week high stock price is 10.30, which is 134.6% above the current share price.
  • The Achieve Life Sciences 52-week low stock price is 3.03, which is 31% below the current share price.
  • The average Achieve Life Sciences stock price for the last 52 weeks is 4.94.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Achieve Life Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 4.4491 4.1700 5.1400 3.8200 4.3900 6.55%
2023 5.2860 2.5300 9.9300 2.4900 4.1200 68.16%
2022 5.3755 8.2600 8.4500 2.0200 2.4500 -68.51%
2021 9.2419 7.9000 15.7700 6.7900 7.7800 -3.95%
2020 17.1316 10.3980 206.6400 4.6000 8.1000 -23.57%
2019 42.8849 25.6000 89.2000 9.6500 10.5980 -56.21%
2018 146.8399 288.0000 404.0000 23.6000 24.2000 -90.99%
2017 763.8446 1121.9999 1539.9998 236.0000 268.6600 -75.57%
2016 1576.5172 2573.9997 2903.9997 768.8999 1099.7799 -58.69%
2015 5032.5868 5103.9995 7919.9992 2507.9997 2661.9997 -47.16%
2014 12024.4821 19799.9980 30469.9970 4465.9996 5037.9995 -72.54%
2013 21888.7319 29457.9971 30007.9970 14739.9985 18347.9982 -36.43%
2012 29717.5530 26157.9974 38345.9962 25387.9975 28863.9971 11.75%
2011 30725.0834 37025.9963 41007.9959 20151.9980 25827.9974 -30.08%
2010 35984.6622 48047.9952 49433.9951 26135.9974 36937.9963 -24.64%
2009 43855.8572 7699.9992 88351.9912 6379.9994 49015.9951 642.67%
2008 12159.5405 17819.9982 19799.9980 4861.9995 6599.9993 -62.12%
2007 154940.1120 238391.9762 242747.9757 15839.9984 17423.9983 -92.80%
2006 210965.4291 203147.9797 263339.9737 171071.9829 241955.9758 21.47%
2005 150300.8421 133451.9867 203939.9796 97019.9903 199187.9801 42.49%
2004 187298.5527 201563.9798 326699.9673 86327.9914 139787.9860 -30.51%
2003 150297.6993 88307.9912 233639.9766 77219.9923 201167.9799 139.62%
2002 141214.8430 318383.9682 328679.9671 53459.9947 83951.9916 -73.76%
2001 139634.6957 26135.9974 329075.9671 22967.9977 319967.9680 1182.54%
2000 137163.7006 111275.9889 398375.9602 17423.9983 24947.9975 -74.80%
1999 211309.9789 292247.9708 376199.9624 87911.9912 98999.9901 -62.96%
1998 627699.2229 1395899.8604 1544399.8456 150875.9849 267299.9733 -79.63%
1997 1278877.9591 1207799.8792 1821599.8178 876347.9124 1311947.8688 11.36%
1996 738630.3513 494999.9505 1207799.8792 425699.9574 1178099.8822 142.86%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.158B $0.000B
Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.455B 29.78
Chugai Pharmaceutical (CHGCY) Japan $50.600B 22.62
Takeda Pharmaceutical (TAK) Japan $41.238B 6.68
Merck (MKGAF) Germany $20.301B 19.16
Astellas Pharma (ALPMY) Japan $17.282B 27.29
Sandoz Group AG (SDZNY) Switzerland $14.137B 0.00
Shionogi (SGIOY) Japan $13.819B 12.39
Neurocrine Biosciences (NBIX) United States $13.532B 56.19
United Therapeutics (UTHR) United States $11.005B 11.79
Catalent (CTLT) United States $10.120B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.712B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.896B 6.99
Revolution Medicines (RVMD) United States $6.131B 0.00
Ionis Pharmaceuticals (IONS) United States $6.062B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.232B 0.00
Madrigal Pharmaceuticals (MDGL) United States $3.847B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.317B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.741B 0.00
Summit Therapeutics (SMMT) United States $2.710B 0.00
Indivior (INDV) United States $2.424B 11.49
Corcept Therapeutics (CORT) United States $2.373B 24.00
PTC Therapeutics (PTCT) United States $2.191B 0.00
Dyne Therapeutics (DYN) United States $2.131B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.963B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.905B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.802B 10.67
Evotec AG (EVO) Germany $1.779B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.757B 18.16
Avadel Pharmaceuticals (AVDL) Ireland $1.613B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 27.90
Ardelyx (ARDX) United States $1.494B 0.00
Soleno Therapeutics (SLNO) United States $1.266B 0.00
Xencor (XNCR) United States $1.232B 0.00
Pacira BioSciences (PCRX) United States $1.225B 12.19
Ironwood Pharmaceuticals (IRWD) United States $1.224B 11.50
Collegium Pharmaceutical (COLL) United States $1.191B 7.33
4D Molecular Therapeutics (FDMT) United States $1.189B 0.00
Cronos Group (CRON) Canada $0.989B 0.00
Cassava Sciences (SAVA) United States $0.966B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.895B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.858B 0.00
Relay Therapeutics (RLAY) United States $0.843B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Sage Therapeutics (SAGE) United States $0.824B 0.00
ARS Pharmaceuticals (SPRY) United States $0.806B 0.00
Enliven Therapeutics (ELVN) United States $0.804B 0.00
Ocular Therapeutix (OCUL) United States $0.734B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.710B 0.00
Silence Therapeutics (SLN) United Kingdom $0.647B 0.00
Siga Technologies (SIGA) United States $0.625B 9.25
Savara (SVRA) United States $0.609B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.581B 0.00
Lyell Immunopharma (LYEL) United States $0.553B 0.00
OmniAb (OABI) United States $0.525B 0.00
Verve Therapeutics (VERV) United States $0.515B 0.00
Altimmune (ALT) United States $0.515B 0.00
Korro Bio (KRRO) United States $0.505B 0.00
Exscientia (EXAI) United Kingdom $0.487B 0.00
ProKidney (PROK) United States $0.486B 0.00
KalVista Pharmaceuticals (KALV) United States $0.455B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.443B 0.00
Lexeo Therapeutics (LXEO) United States $0.412B 0.00
Larimar Therapeutics (LRMR) United States $0.411B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Harrow (HROW) United States $0.372B 0.00
Heron Therapeutics (HRTX) United States $0.368B 0.00
Nature's Sunshine Products (NATR) United States $0.367B 20.53
Corbus Pharmaceuticals Holdings (CRBP) United States $0.360B 0.00
Esperion Therapeutics (ESPR) United States $0.360B 0.00
Fractyl Health (GUTS) United States $0.321B 0.00
Bioventus (BVS) United States $0.315B 0.00
Organogenesis (ORGO) United States $0.310B 58.75
Black Diamond Therapeutics (BDTX) United States $0.309B 0.00
Aquestive Therapeutics (AQST) United States $0.298B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Metagenomi (MGX) United States $0.282B 0.00
Lyra Therapeutics (LYRA) United States $0.282B 0.00
Akebia Therapeutics (AKBA) United States $0.281B 0.00
Nanobiotix S.A (NBTX) France $0.271B 0.00
ESSA Pharma (EPIX) Canada $0.269B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.259B 0.00
Pyxis Oncology (PYXS) United States $0.250B 0.00
Adherex Technologies (FENC) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Conduit Pharmaceuticals (CDT) United States $0.234B 0.00
Foghorn Therapeutics (FHTX) United States $0.234B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Prelude Therapeutics (PRLD) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.220B 0.00
Galectin Therapeutics (GALT) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Telomir Pharmaceuticals (TELO) United States $0.203B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.193B 0.00
Acrivon Therapeutics (ACRV) United States $0.192B 0.00
Century Therapeutics (IPSC) United States $0.187B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Regulus Therapeutics (RGLS) United States $0.158B 0.00
CytoDyn (CYDY) United States $0.142B 0.00
Elite Pharmaceuticals (ELTP) United States $0.142B 13.25
Incannex Healthcare (IXHL) Australia $0.141B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Karyopharm Therapeutics (KPTI) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.120B 2.51
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Eliem Therapeutics (ELYM) United States $0.110B 0.00
Citius Pharmaceuticals (CTXR) United States $0.106B 0.00
GlycoMimetics (GLYC) United States $0.106B 0.00
Inotiv (NOTV) United States $0.104B 0.00
FibroGen (FGEN) United States $0.103B 0.00
OptiNose (OPTN) United States $0.097B 0.00
AlloVir (ALVR) United States $0.092B 0.00
PMV Pharmaceuticals (PMVP) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
ProPhase Labs (PRPH) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.079B 6.37
Tempest Therapeutics (TPST) United States $0.079B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.87
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Jaguar Animal Health (JAGX) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
JanOne (JAN) United States $0.044B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.032B 0.00
DURECT (DRRX) United States $0.029B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Nutriband (NTRB) United States $0.028B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.025B 11.73
PolyPid (PYPD) Israel $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Addex Therapeutics (ADXN) Switzerland $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Avalo Therapeutics (AVTX) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
SHINECO (SISI) China $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.24
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.42